Interviews

Pharmacy Times® interviewed Chad Landmon, the chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the potential impact President-elect Joseph Biden’s cabinet nominations may have on the pharmacy field in 2021.

Although safety and efficacy have been proven, a few questions still remain about how long the vaccines will be effective and whether they prevent asymptomatic infection.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the rollout of phase 1b and c of COVID-19 vaccinations at Walgreens pharmacies.

One of the main challenges with the distribution process is that each state has its own jurisdictional plan, which can create some confusion.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.

Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.

Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a letter that was signed by President-elect Biden’s pick for HHS secretary to the outgoing HHS secretary on the enforcement of 340B drug pricing laws.

In a recent interview with Pharmacy Times, Barbara Giacomelli, BS Pharm, PharmD, discussed the trends she hopes to see in the pharmacy field in 2021 and where she sees the landscape changing.

Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on how pharmacies and their patients are affected by issues regarding the regulation of the sale of 340B discounted drugs.

Having a shared cultural understanding allows the pharmacy to make medical and educational interventions relevant to the patient and allows patients to actively participate in their care.

Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a lawsuit filed against the HHS and HRSA regarding the sale of 340B discounted drugs.

Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.

Randall A. Oyer, MD, discusses rising cancer mortality during the coronavirus disease 2019 (COVID-19) pandemic and what that means for cancer care.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for immunizing staff at a hospital pharmacy with the COVID-19 vaccines.

Pharmacy Times® interviewed Michael Flannery, PharmD, of the University of Rochester Medical Center, on the process that the hospital pharmacy has developed for vaccinations following the arrival of the Pfizer and Moderna COVID-19 vaccines.

Pharmacy Times® interviewed Jason Kay, PharmD, MS, the director of pharmacy programs at of Blue Cross Blue Shield Association, on how the recent drop in immunizations among children may result in the rise of certain highly contagious diseases.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the concerns he has regarding the COVID-19 vaccination process ahead.

Pharmacy Times® interviewed Emily Cook, JD, a partner with McDermott Will & Emery, on the final 340B dispute resolution rule, which was recently sent by the HHS to the OMB for review.

Pharmacy Times® interviewed Sue Peschin of the COVID-19 Vaccine Education and Equity Project on the role of pharmacies in vaccinating the public with the COVID-19 vaccines.

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to support education about and equitable access to COVID-19 vaccines.

Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on how pharmacists can help people come back for the second dose of the COVID-19 vaccine.

Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on some of the challenges community pharmacies may need to manage when receiving and administering COVID-19 vaccines.

Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on the work needed to prepare for the arrival and administration of COVID-19 vaccines.

Pharmacy Times® interviewed Signe Pringle, the assistant secretary for the Maryland Department of Commerce, on a signed partnership between Quebec and Maryland to foster collaboration around health science research during COVID-19 and beyond.

In an interview with Pharmacy Times, Stefan Behrens, PhD, CEO and co-founder of GYANT, and Justin Graham, MD, MS, chief medical officer, said preparing patients for the process of receiving a coronavirus disease 2019 (COVID-19) vaccine is essential.